Clinical Significance
- Determining tumor sensitivity to Imatinib and other inhibitors.
- Predicting disease progression and clinical prognosis.
- Tailoring personalized therapy based on the specific mutation type.
Book GIST Genetic Analysis | Lahalak Medical Platform
Identify the most effective targeted therapy for Gastrointestinal Stromal Tumors through advanced molecular analysis, helping your oncologist select personalized treatments for significantly improved clinical outcomes and recovery.
Scientific name: GIST Molecular Mutational Analysis (KIT/PDGFRA)
A specialized molecular test analyzing KIT and PDGFRA mutations in GIST samples. It guides oncologists in selecting optimal targeted therapies and predicting treatment response for better patient management.
Service type
Advanced Genetic Testing
Duration
7-10 working days
Fasting
Fasting is not required
Included Services
- KIT Mutation Analysis
- PDGFRA Mutation Analysis
- Detailed Medical Report
Medical Service Information
Who Should Get This Test?
- Patients newly diagnosed with Gastrointestinal Stromal Tumors (GIST).
- Patients starting targeted therapy protocols.
- Cases showing resistance to current treatment for re-evaluation.
Understanding Results
- KIT mutations often correlate with positive response to standard inhibitors.
- PDGFRA mutations help identify specific drug resistance or sensitivity.
- Wild-type results guide doctors toward alternative genetic pathways.
Conditions & Notices
- Requires a formal tissue sample (paraffin block) from the tumor
Medical services you might also like
